CL logo

Colgate-Palmolive (CL)

Profile

Full Name

Colgate-Palmolive Company

Ticker Symbol

CL

Exchange

NYSE

Sector

Consumer Defensive

Industry

Household & Personal Products

Country

United States

IPO

May 2, 1973

Indexes

S&P 500

Website

http://www.colgatepalmolive.com

Employees

34000

Key Details

Price

$90.48(-0.23%)

Market cap

Last Dividend

$0.52

TTM Dividend yield

2.23%

Annual revenue

$20.10B(+3.31% YoY)

Annual EPS

$3.51(+26.71% YoY)

PE ratio

25.56

Next earnings date

Jul 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$90.48
CL price is $90.48

30-Day Relative Volume

0.77
CL 30-day relative volume is 0.77

Price Performance

Price Most recent change

-0.23%
CL price was down -0.23% on May 2, 2025

Price YTD change

-0.47%
CL price is down -0.47% since January 1st

Price 1-year change

-2.62%
CL price is down -2.62% year-on-year

Price 3-year change

+20.35%
CL price is up +20.35% over the past 3 years

Price Range

Price All-time high

$109.30
CL price is currently -17.22% below its historical high of $109.30

Price 3-year low

$67.62
CL price is currently +33.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$73.33B
CL market capitalization is $73.33 billion

Market cap 3-year change

+16.4%
CL market capitalization is up +16.4% over the past 3 years

Market cap All-time high

$88.82B
CL market capitalization is currently -17.44% below its historical high of $88.82 billion

Market cap sector rank

95.33%
CL market capitalization is higher than 95.33% of companies in Consumer Defensive sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.22%
CL shares outstanding is down -1.22% year-on-year

Shares Outstanding 3-Year Change

-3.28%
CL shares outstanding is down -3.28% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.06
CL beta is 0.06

200-day SMA

$95.35
CL price is currently -5.11% below its 200-day simple moving average

50-day SMA

$92.20
CL price is currently -1.87% below its 50-day simple moving average

RSI

44.14
CL 14-day relative strength index is 44.14

Volume

0.77
CL 30-day relative volume is 0.77

ATR

$2.75
CL average true range is $2.75

10-day Historical Volatility

24.52%
CL 10-day historical volatility is 24.52%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.52
CL last dividend was $0.52 per share, with an ex-dividend date of April 17, 2025

Next Dividend

-
CL next dividend has not yet been announced

Dividend per share

Dividend per share

$1.98
CL annual dividend per share is $1.98

Dividend per share Sector Rank

64.65%
CL annual dividend per share is higher than 64.65% of companies in Consumer Defensive sector

Dividend per share 1-Year Change

+3.66%
CL annual dividend per share is up +3.66% year-on-year

Dividend per share 3-Year Change

+10.61%
CL annual dividend per share is up +10.61% over the past 3 years

Dividend yield

Dividend yield

2.19%
CL annual dividend yield is 2.19%

Dividend yield Sector Rank

28.28%
CL annual dividend yield is higher than 28.28% of companies in Consumer Defensive sector

Other

Payout ratio

61.92%
CL annual payout ratio is 61.92%

Dividends paid

$1.79B
CL annual dividends paid is $1.79 billion

Free cash flow

$3.55B
CL annual free cash flow is $3.55 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$20.10B
CL annual revenue is $20.10 billion

Revenue Analysts estimate

$20.27B
CL annual revenue is currently -0.83% lower than the consensus analysts' forecast

Revenue 1-year change

+3.31%
CL annual revenue is up +3.31% year-on-year

Revenue Sector rank

89.58%
CL annual revenue is higher than 89.58% of companies in Consumer Defensive sector

EPS

EPS

$3.51
CL annual earnings per share is $3.51

EPS Analysts estimate

$3.66
CL annual earnings per share is currently -4.06% lower than the consensus analysts' forecast

EPS 1-year change

+26.71%
CL annual earnings per share is up +26.71% year-on-year

EPS Sector rank

81.64%
CL annual earnings per share is higher than 81.64% of companies in Consumer Defensive sector

Profit

Gross profit

$12.16B
CL annual gross profit is $12.16 billion

Gross margin

60.50%
CL annual gross profit margin is 60.50%

Operating profit

$4.27B
CL annual operating income is $4.27 billion

Operating margin

21.23%
CL annual operating profit margin is 21.23%

Net income

$2.89B
CL annual net profit is $2.89 billion

Net margin

14.37%
CL annual net profit margin is 14.37%

Expenses

Total expenses

$15.83B
CL annual total expenses is $15.83 billion

Operating expenses

$7.89B
CL annual total operating expenses is $7.89 billion

Cost of goods sold

$7.94B
CL annual cost of goods sold is $7.94 billion

Selling, general & administrative expenses

$7.73B
CL annual SGA is $7.73 billion

Depreciation and amortization

$605.00M
CL annual depreciation & amortization is $605.00 million

Interest expense

$292.00M
CL annual interest expense is $292.00 million

Income tax

$907.00M
CL annual income tax is $907.00 million

EBIT & EBITDA

EBIT

$4.25B
CL annual earnings before interest & taxes is $4.25 billion

EBITDA

$4.85B
CL annual EBITDA is $4.85 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$16.05B
CL annual total assets is $16.05 billion

Non current assets

$10.73B
CL annual long term assets is $10.73 billion

Current assets

$5.32B
CL annual total current assets is $5.32 billion

Cash and cash equivalents

$1.10B
CL annual cash & cash equivalents is $1.10 billion

Accounts receivable

$1.52B
CL annual accounts receivable is $1.52 billion

Inventory

$1.99B
CL annual inventory is $1.99 billion

Liabilities

Total liabilities

$15.50B
CL annual total liabilities is $15.50 billion

Long term liabilities

$10.40B
CL annual total long term liabilities is $10.40 billion

Current liabilities

$5.10B
CL annual total current liabilities is $5.10 billion

Accounts payable

$1.80B
CL annual accounts payable is $1.80 billion

Debt

Total debt

$8.72B
CL annual total debt is $8.72 billion

Total debt 1-year change

-3.84%
CL annual total debt is down -3.84% year-on-year

Long term debt

$7.95B
CL annual long term debt is $7.95 billion

Short term debt

$767.00M
CL annual short term debt is $767.00 million

Equity & Capital

Shareholders equity

$212.00M
CL annual stockholders equity is $212.00 million

Book value

$212.00M
CL annual book value is $212.00 million

Retained earnings

$26.14B
CL annual retained earnings is $26.14 billion

Working capital

$218.00M
CL annual working capital is $218.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$4.11B
CL annual cash flow from operations is $4.11 billion

Cash from operations 1-year change

+9.67%
CL annual cash flow from operations is up +9.67% year-on-year

Cash from investing

-$534.00M
CL annual cash flow from investing activities is -$534.00 million

Cash from investing 1-year change

+28.03%
CL annual cash flow from investing activities is up +28.03% year-on-year

Cash from financing

-$3.39B
CL annual cash flow from financing activities is -$3.39 billion

Cash from financing 1-year change

-21.34%
CL annual cash flow from financing activities is down -21.34% year-on-year

CAPEX

CAPEX

$561.00M
CL annual capital expenditures is $561.00 million

CAPEX 1-year change

-20.43%
CL annual capital expenditures is down -20.43% year-on-year

Free Cash Flow

Free cash flow

$3.55B
CL annual free cash flow is $3.55 billion

Free cash flow 1-year change

+16.64%
CL annual free cash flow is up +16.64% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.50%
CL annual gross profit margin is 60.50%

Operating margin

21.23%
CL annual operating profit margin is 21.23%

Net margin

14.37%
CL annual net profit margin is 14.37%

ROA & ROE

ROA

17.81%
CL annual return on assets is 17.81%

ROE

384.94%
CL annual return on equity is 384.94%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

25.56
CL price to earnings ratio is 25.56

PE ratio Sector rank

64.71%
CL price to earnings ratio is higher than 64.71% of companies in Consumer Defensive sector

PB Ratio

PB ratio

202.00
CL price to book ratio is 202.00

PB ratio Sector rank

99.61%
CL price to book ratio is higher than 99.61% of companies in Consumer Defensive sector

PS Ratio

PS ratio

3.68
CL price to sales ratio is 3.68

PS ratio Sector rank

88.34%
CL price to sales ratio is higher than 88.34% of companies in Consumer Defensive sector

Enterprise value

Enterprise value

$80.48B
CL enterprise value is $80.48 billion

Enterprise value Sector rank

94.88%
CL enterprise value is higher than 94.88% of companies in Consumer Defensive sector

EV/EBITDA

EV/EBITDA

16.69
CL EV/EBITDA is 16.69

EV/EBITDA Sector rank

78.38%
CL EV/EBITDA is higher than 78.38% of companies in Consumer Defensive sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.04
CL annual current ratio is 1.04

Quick ratio

0.65
CL annual quick ratio is 0.65

Leverage

Debt to equity

37.50
CL annual debt to equity ratio is 37.50

Interest coverage ratio

14.55
CL annual interest coverage ratio is 14.55

Risk & Stability

Piotroski F-Score

7
CL piotroski f-score is 7

Altman Z-Score

7.26
CL altman z-score is 7.26

Analyst ratings

Recent major analysts updates

Apr 28, 25 JP Morgan
Overweight
Apr 28, 25 Citigroup
Buy
Apr 17, 25 UBS
Buy
Apr 11, 25 JP Morgan
Overweight
Apr 11, 25 Barclays
Equal-Weight
Apr 2, 25 Wells Fargo
Underweight
Mar 31, 25 Piper Sandler
Overweight
Mar 27, 25 Barclays
Equal-Weight
Mar 14, 25 JP Morgan
Overweight
Feb 3, 25 UBS
Buy

Institutional Ownership

Similar stocks

DEO logo
Diageo (DEO)
MDLZ logo
Mondelez International (MDLZ)
MNST logo
Monster Beverage (MNST)
BTI logo
British American Tobacco (BTI)
KR logo
Kroger Co (KR)
KDP logo
Keurig Dr Pepper (KDP)
MO logo
Altria (MO)
KVUE logo
Kenvue (KVUE)
TGT logo
Target (TGT)
  • What is the ticker symbol for Colgate-Palmolive?
  • Does Colgate-Palmolive pay dividends?
  • What sector is Colgate-Palmolive in?
  • What industry is Colgate-Palmolive in?
  • What country is Colgate-Palmolive based in?
  • When did Colgate-Palmolive go public?
  • Is Colgate-Palmolive in the S&P 500?
  • Is Colgate-Palmolive in the NASDAQ 100?
  • Is Colgate-Palmolive in the Dow Jones?
  • When was Colgate-Palmolive's last earnings report?
  • When does Colgate-Palmolive report earnings?
  • Should I buy Colgate-Palmolive stock now?

What is the ticker symbol for Colgate-Palmolive?

The ticker symbol for Colgate-Palmolive is NYSE:CL

Does Colgate-Palmolive pay dividends?

Yes, Colgate-Palmolive pays dividends. The last payment was $0.52, with an ex-dividend date on April 17, 2025

What sector is Colgate-Palmolive in?

Colgate-Palmolive is in the Consumer Defensive sector

What industry is Colgate-Palmolive in?

Colgate-Palmolive is in the Household & Personal Products industry

What country is Colgate-Palmolive based in?

Colgate-Palmolive is headquartered in United States

When did Colgate-Palmolive go public?

Colgate-Palmolive's initial public offering (IPO) was on May 2, 1973

Is Colgate-Palmolive in the S&P 500?

Yes, Colgate-Palmolive is included in the S&P 500 index

Is Colgate-Palmolive in the NASDAQ 100?

No, Colgate-Palmolive is not included in the NASDAQ 100 index

Is Colgate-Palmolive in the Dow Jones?

No, Colgate-Palmolive is not included in the Dow Jones index

When was Colgate-Palmolive's last earnings report?

Colgate-Palmolive's most recent earnings report was on Apr 25, 2025

When does Colgate-Palmolive report earnings?

The next expected earnings date for Colgate-Palmolive is Jul 25, 2025

Should I buy Colgate-Palmolive stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page